1-6 of 174 Activities
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this OnDemand, CME Outfitters Webcast, expert faculty will discuss strategies for identifying the physiologic biopsychosocial factors that influence pain, utilizing pain assessment tools that reinforce approaches to the appropriate management of pain, implementing strategies from the 2022 CDC Guideline for Prescribing Opioids into the development of safe and effective pain management plans, and other valuable skills for improving the treatment of patients suffering from chronic pain.
In this CME Outfitters recorded webcast, expert faculty will examine socioeconomic, geographic, and systemic factors that contribute to disparities in clinical trial access, particularly in underserved or community-based settings. Faculty will help learners identify interprofessional strategies, including use of culturally responsive communication, patient navigators, and advocacy partnerships, to engage underrepresented patients in clinical trial discussions and enrollment.
In the sixth activity of this CME Outfitters Snack series, expert faculty will demonstrate integration of specific resources on AE mitigation and expectations as part of regular counseling for patients treated with GLP-1 RAs to improve adherence. Learners will be shown how to integrate GLP-1 RAs into a broader T2D management plan by detecting and addressing barriers to access and optimal utilization.
This second of four CME Outfitters Snacks features metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic-associated steatohepatitis (MASH) experts Monica Tincopa, MD, and Amreen Dinani, MD.
In this CME Outfitters enduring webcast, expert faculty will discuss strategies to better assess the impact of diagnostic delays in IH and narcolepsy, differentiate the effects of treatment selections, with an emphasis on CV risk and patient-specific considerations, and evaluate the sleep/wake cycle and its relationship to narcolepsy and IH to optimize its evaluation and management.
